“Almost all of the studies reported improved erectile function in various animal models of CN (Cavernous Nerve) injury, vascular insufficiency, diabetes mellitus, hyperlipidemia, and aging… a single intracavernous injection of autologous ADSCs (Adipose-Derived Stem Cells) in 17 men (aged 46~69 years) with severe, refractory, post-prostatectomy ED resulting from surgery 5~18 months prior to enrollment…. 8 of the 17 men recovered erectile function with the ability to accomplish sexual intercourse.”